| Location | Framingham, MA |
| Salary | $191,500–$247,500 Per Year |
Overview
Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient's lives depend on it.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.
Audacious: We Are Bold.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other.
People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.
Join us, as we reshape the future.
Summary of job description:
Reporting to the Senior Director, Quality Assurance, the Director, Quality Systems
supports the development and implementation of Replimune quality systems to ensure
compliance with US and international regulations, laws and guidelines including ICH 010.
The Director, Quality Systems has the opportunity to create influential and collaborative
relationships for Quality across the company and will be accountable for but not limited to; training, documentation, vendor management, change control, corrective action
preventative action (CAPA), deviation management and quality metrics development and
reporting. Managing and maintaining eDMS tools are essential to the role, as is
management of the international quality systems team.
Key responsibilities:
Q10 including the following components:
Document Management
Training compliance
Change Control
Deviation Management
CAPA
Quality Metrics Reporting and Trending
Monitor and report to management on the quality system health
Drive quality system initiatives and improvement activities while partnering across
functions and sites.
organization to ensure compliance with industry expectations.
customer service to the business.
risks along with development and execution of actions focused on risk mitigation. This
includes identification of interim controls and influencing stakeholders to drive timely
action where mitigation is required and assist with coordinating inspection responses
within defined regulatory timelines and generation of the associated CAPA plans.
projects and initiatives.
involved in the execution of Quality System processes.
quality system tools (MasterControl).
Experience and skills requirements:
pharmaceutical industry.
or both desirable.
relationships with key stakeholders.
working effectively in a team-oriented environment
Educational requirements:
degree in a biological or pharma industry area preferred.
Salary Range
Replimune is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $191,500-$247,500. The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate's unique set of qualifications, skills, and experience. Our current organizational needs also play a part in determining your final offer.
At Replimune, base pay is only one part of your total compensation package. The selected candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Replimune also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays including year-end shutdown.
About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune's proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.
We are an Equal Opportunity Employer.